Live feed08:00:00·143dPRReleasevia QuantisnowBenitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of ResponseByQuantisnow·Wall Street's wire, on your screen.BNTC· Benitec Biopharma Inc.Health Care
